Anastrozole and Related Glucuronic Acid Conjugate are Electrophilic Species
Xenobiotica. 2022 Jun 3:1-12. doi: 10.1080/00498254.2022.2086503. Online ahead of print.ABSTRACTAnastrozole (ANA), is an inhibitor of non-steroidal aromatase, widely employed for the treatment of breast cancer. However, ANA-associated liver injury cases have been documented in the application of the drug.The major purposes of the present study were to identify the structure of reactive metabolites derived from ANA and to study related metabolic pathways of ANA.We found ANA itself is an electrophilic species reactive to GSH. ANA can be metabolized to ANA-N+-glucuronide (1) catalyzed by UGT1A4. An ANA GSH conjugate (2) was detected in bile and livers of rats treated with ANA. UGT1A4 participated in the phase II metabolic pathway.This work allowed us to better understand the mechanisms of the hepatotoxicity of ANA and provided new avenue to define the possible role of metabolic activation in hepatotoxicity.PMID:35656966 | DOI:10.1080/00498254.2022.2086503
Source: Cancer Control - Category: Cancer & Oncology Authors: Siyu Ding Siyu Liu Yaxuan Chen Ying Peng Jiang Zheng Source Type: research
More News: Arimidex | Bile | Breast Cancer | Cancer | Cancer & Oncology | Liver | Study | Urology & Nephrology